Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve Children
Status:
Completed
Trial end date:
2020-03-10
Target enrollment:
Participant gender:
Summary
Chronic hepatitis C virus (HCV) infection represents a crucial health problem in children
that greatly influence their quality of life. Many efforts have been directed toward the
investment of effective drugs with high safety profiles and with oral administration for
better compliance. The development of a new direct-acting antiviral (DAA) made it possible to
achieve these goals.
Phase:
Phase 2
Details
Lead Sponsor:
Mansoura University Children Hospital
Treatments:
Ledipasvir Ledipasvir, sofosbuvir drug combination Sofosbuvir